Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford University has been selected as the home of the new Podium Analytics Institute for Youth Sports Medicine and Technology. This will be the world’s first academic Institute focused on young athletes’ safety and lifelong health and will combine Oxford’s longstanding tradition in sports and education with the very best of science, medicine, and technology.

Student looking at a brain scan

The new Institute will shift the traditional emphasis of research into sports injury - which is predominantly adult-centric and based upon treatment – by concentrating on younger athletes, 11-18 years old, and will focus on prevention rather than cure.

The institute will develop new technologies to monitor and analyse the individual factors that currently lead to youth sports injuries and offer practical solutions for safer sports practices, focusing on safety for lifelong health, rather than performance.

‘Sport-related injury, particularly concussion, have rapidly risen to the top of under-reported and under-researched issues with lifelong consequences for both individual athletes and society. This partnership, and the new Institute, will combine the best of science, medicine and technology to deliver research that can have a real-world and measurable impact on young people’s lives.’ Prof Louise Richardson, Vice-Chancellor of the University of Oxford 

The Institute will form part of the Institute of Biomedical Engineering (Department of Engineering Science) - which has a 15-year track-record of combining medicine and technology to achieve adoption and healthcare impact - and will draw on leading expertise across the medical sciences, including clinical neurosciences, orthopaedics, and population health, as well as Oxford’s Big Data Institute

Read the full story on the University of Oxford website

Similar stories

RECOVERY trial team awarded MRC Impact Prize for Outstanding Team Impact

The Medical Research Council Prize Committee has awarded the RECOVERY trial team the MRC Impact Prize 2022 for Outstanding Team Impact.

Professor Sir Chris Whitty brings greater understanding of epidemics to Oxford

Chief Medical Officer of England Professor Sir Chris Whitty KCB FMedSci delivers the Sherrington Prize Lecture: Public Understanding of Science to an audience of Oxford staff and students.

Multiple Debilitating Pains – New global study shows the experience of Endometriosis is rooted in a person’s genetics

Researchers at the University of Oxford in collaboration with 25 teams across the world have published the largest study to date of the genetic basis of endometriosis.

Study shows delaying treatment for localised prostate cancer does not increase mortality risk

Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind.

Showcasing Oxford’s translational research for Rare Disease Day

Rare Disease Day is an annual awareness day that aims to educate and raise awareness for the 400 million people worldwide who live with a rare disease.

Prostate cancer AI diagnosis tool begins evaluation in Oxford

New artificial intelligence software that can help to spot prostate cancer is being trialled by researchers at Oxford University Hospitals (OUH) NHS Foundation Trust.